Developed by the PHA Scientific Leadership Council, this program will offer, at nationally recognized PAH centers, direct instruction on state-of-the-art PAH diagnosis and management for physicians and other health professionals who help care for patients with PAH.
These day-long highly interactive preceptorships will build links among community PAH specialists, non-specialists, and clinicians at established PAH centers, creating new avenues for communication and more comprehensive, state-of-the-art diagnosis, initial treatment, and long-term management of patients with PAH.
- All programs will be scheduled from 9:00 a.m. - 3:30 p.m.
- A complimentary breakfast and lunch will be provided
- This program is FREE
Target Audience
This activity has been designed for pulmonologists, cardiologists, rheumatologists, internists, and primary care physicians, as well as nurses, physician assistants, and other allied health professionals who help care for patients with PAH.
Educational Objectives
The PHA Preceptorship Program is designed to improve competence, performance, and patient care practices by instructing front-line clinicians in the highest quality of care for patients with PAH. At the conclusion of this program, participants should be able to:
- Define key pathophysiologic and epidemiologic components of PAH
- Accurately diagnose patients through comprehensive screening and early recognition of symptoms
- Evaluate the patient's condition and prescribe optimal long-term management, including knowing when and how to treat and when to consult with colleagues at an established PAH center
- Tailor comprehensive care for complex patient populations
Accreditation and Credit Designation
This live activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Washington University School of Medicine, Continuing Medical Education and the Pulmonary Hypertension Association. Washington University is accredited by the ACCME to provide continuing medical education for physicians.
Washington University designates this live activity for a maximum of 5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Upcoming Programs
|
June 14, 2013
|
Ann Arbor, MI
|
|
August 2, 2013
|
Cincinnati, OH
|

Programs Have Taken Place in the Following Cities
|
November 16, 2012
|
New York, NY
|
|
November 9, 2012
|
Salt Lake City, UT
|
|
November 9, 2012
|
Minneapolis, MN
|
|
November 2, 2012
|
Dallas, TX
|
|
September 28, 2012
|
Columbus, OH
|
|
September 21, 2012
|
Baltimore, MD
|
|
September 21, 2012
|
St. Louis, MO
|
|
August 10, 2012
|
Orlando, FL
|
|
June 8, 2012
|
Boston, MA
|
|
June 1, 2012
|
San Diego, CA
|
DIAMOND SUPPORTER
|
PLATINUM SUPPORTER
|
GOLD SUPPORTER
|
SILVER SUPPORTER
|
| Actelion Pharmaceuticals US, Inc. |
Gilead Sciences, Inc. |
United Therapeutics Corporation |
Bayer HealthCare |
This is a program of the PHA Medical Education Fund, made possible through unrestricted educational grants from our supporters.